JW Pharmaceutical Corporation (001067.KS) KSC
45,600.00
-3200(-6.56%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
45,600.00
-3200(-6.56%)
Currency In KRW
Address
2477, Nambusunhwan-ro
Seoul, 137-864
Korea (the Republic of)
Phone
82 2 840 6777
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1064
First IPO Date
September 29, 2005
| Name | Title | Pay | Year Born |
| Sung-Yeol Lee | Chief Executive Officer, Head of Product Development & Management and Director | 0 | N/A |
| Young-Sub Shin | Chief Executive Officer, Head of Sales & Marketing and Inside Director | 0 | 1963 |
| Jae-Kwang Jeon | Head Managing Director and Head of Public Relation | 0 | 1962 |
| Hyun-seok Han | Head of Product Plant | 0 | 1962 |
| Kim Yong Kwan | Development Head & Internal Director | 0 | N/A |
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.